v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash Flows Used in Operating Activities              
Net loss $ (17,993) $ (11,557) $ (33,949) $ (12,539) $ (49,880) $ (31,982)  
Adjustment to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         1,008 970  
Amortization of intangible assets         4,559 3,571  
Amortization of right of use asset         536 527  
Stock based compensation 700   1,700   2,962 8,813  
Earnout expense valuation benefit         (2,827) 0  
Loss on exchange of debt for equity 0   0   0 30  
Amortization of debt discount         0 224  
Amortization of original issued discount         121 0  
Accrued interest income, related party         (278) (1,627)  
Provision for doubtful accounts         5 100  
Unrealized gain on note         1,870 (638)  
Provision for inventory obsolescense         0 300  
Recovery for valuation allowance for held for sale loan 0   0   0 (7,345)  
Gain on settlement of related party promissory note and loan related party receivable 0   0   0 (49,817)  
Deferred income tax         (1) (4,507)  
Loss on disposal of property and equipment         1 0  
Unrealized gain/(loss) on equity securities 5,854   22,285   7,110 51,250  
Impairment of goodwill 0   0   7,570 0  
Realized loss on sale of equity securities         151 0  
Gain on conversion of note receivable         (791) 0  
Other         196 137  
Changes in operating assets and liabilities:              
Accounts receivable and other receivables         336 (678)  
Inventory         (1,002) (499)  
Prepaid expenses and other current assets         1,545 (70)  
Other assets         28 200  
Accounts payable         237 (653)  
Accrued liabilities         1,059 3,421  
Income tax liabilities         (38) 3,471  
Deferred revenue         (915) 1,214  
Operating lease obligation         (505) (519)  
Other liabilities         0 89  
Net Cash Used in Operating Activities         (26,943) (24,018)  
Cash Flows Used in Investing Activities              
Purchase of property and equipment         (221) (258)  
Investment in capitalized software         (611) (857)  
Purchase of other short term investments         0 (2,000)  
Sales of other short term investments         0 2,000  
Purchase of convertible note         (5,500) 0  
Sales of equity securities         229 0  
Purchases of treasury bills         0 (63,362)  
Sales of treasury bills         43,001 28,000  
Purchase of Systat licensing agreement         0 (900)  
Issuance of note receivable         (150) (268)  
Acquisition of Ten Degrees         0 184  
Acquisition of CXApp         0 (15,186)  
Acquisition of Visualix         0 (61)  
Net Cash Provided By (Used in) Investing Activities         36,748 (52,708)  
Cash From Financing Activities              
Net proceeds from issuance of preferred stock and warrants         46,906 50,584  
Net proceeds from issuance of common stock and warrants         0 77,853  
Net proceeds from promissory note         5,539 0  
Cash paid for redemption of preferred stock series 7         (49,250) 0  
Taxes paid related to net share settlement of restricted stock units         (336) (1,687)  
Loans to related party         0 (117)  
Repayment of CXApp acquisition liability         (1,957) (241)  
Repayment of acquisition liability to Nanotron shareholders         0 (467)  
Repayment of acquisition liability to Locality shareholders         0 (500)  
Net Cash Provided By Financing Activities         902 125,425  
Effect of Foreign Exchange Rate on Changes on Cash         (34) 90  
Net Increase in Cash and Cash Equivalents         10,673 48,789  
Cash and Cash Equivalents - Beginning of period   $ 52,480   $ 17,996 52,480 17,996 $ 17,996
Cash and Cash Equivalents - End of period $ 63,153   $ 66,785   63,153 66,785 $ 52,480
Cash paid for:              
Interest         2 3  
Income Taxes         100 2,387  
Non-cash investing and financing activities              
Common shares issued for extinguishment of debt         3,250 2,500  
Common shares issued for CXApp Earnout Payment         3,697 0  
Common shares issued in exchange for warrants         14 0  
Right of use asset obtained in exchange for lease liability         284 0  
Settlement of Sysorex Note         0 7,462  
Investment in equity securities through conversion of note receivable         6,776 58,905  
Common shares issued for CXApp acquisition         0 10,000  
Common shares issued for Game Your Game acquisition         0 1,403  
Common shares issued for Visualix asset acquisition         0 429  
Preferred shares converted into common shares         $ 0 $ 9,500  

Source